Summary
Updated Aug 31, 2026
Dennis Yamashita is Chief Scientific Officer of Kintara Therapeutics, Inc. (HURA). 1 SEC Form 4 filing on record, dated 22 October 2024.
Trading Pattern
InsiderAlpha's records for Dennis Yamashita go back to 2024: 1 primary Form 4 filing, an average of 0.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Dennis Yamashita's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Fairmount Funds Management LLC - $370.02M of COGT open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $327.32M of CELC open-market activity in the last 12 months
- J.H. Whitney Equity Partners VII, LLC - $319.15M of AVAH open-market activity in the last 12 months
- GENERAL ATLANTIC, L.P. - $315.49M of ALHC open-market activity in the last 12 months
- General Atlantic (ALN HLTH), L.P. - $315.49M of ALHC open-market activity in the last 12 months
- August J. Troendle - $249.99M of MEDP open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Dennis Yamashita?
Dennis Yamashita is a corporate insider, tracked as Chief Scientific Officer of Kintara Therapeutics, Inc. (HURA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Dennis Yamashita last file a Form 4?
The only primary Form 4 on record is dated 22 October 2024.
Where can I see all of Dennis Yamashita's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Dennis Yamashita and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial